Correlation Between Lyra Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on Lyra Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Tempest Therapeutics.
Diversification Opportunities for Lyra Therapeutics and Tempest Therapeutics
0.56 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Lyra and Tempest is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Tempest Therapeutics
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Tempest Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Lyra Therapeutics is 7.27 times less risky than Tempest Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The Tempest Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 165.00 in Tempest Therapeutics on August 24, 2024 and sell it today you would lose (74.00) from holding Tempest Therapeutics or give up 44.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Tempest Therapeutics
Performance |
| Timeline |
| Lyra Therapeutics |
| Tempest Therapeutics |
Lyra Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite Lyra Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
| Tempest Therapeutics vs. Lyra Therapeutics | Tempest Therapeutics vs. Hookipa Pharma | Tempest Therapeutics vs. Cingulate Warrants | Tempest Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |